Schroders has launched two new funds on its alternative UCITS platform, giving investors access to both a US equity long-short fund and a US equity market neutral fund.
Schroder GAIA Nuveen US Equity Market Neutral and Schroder GAIA Nuveen US Equity Market Neutral are focused primarily on large-cap US equities, offering daily liquidity without a performance fee.
The launches give investors outside of the US access to Nuveen’s US equity long short strategies for the first time. The existing strategies boast robust six-year performance records and have a combined USD1.2 billion in assets under management (AUM).
Andrew Dreaneen, Head of Liquid Alternatives, Schroders, says: “Schroders and Nuveen both share long-standing investment traditions and the same enduring philosophy – to best meet our clients’ investment needs.
“This is another excellent addition to Schroders’ GAIA platform, which provides investors with access to leading alternative managers in a liquid and regulated format.”
The funds are available on Schroders’ GAIA platform, which continues to grow with 11 strategies and USD6.2 billion AUM in total. In December 2018, Schroders launched its GAIA Helix fund, a single access point for investors looking to harness an optimal blend of Schroders’ alpha-generating strategies.
The funds will be managed by US equity veteran Bob Doll (pictured) and his deputy Scott Tonneson supported by an experienced team of fundamental and quantitative analysts.
The Nuveen funds give investors a market-leading blend of fundamental bottom-up stock-driven research and advanced quantitative analysis through Nuveen’s integrated research platform. They rank companies in the Russell 1000 from the most to the least attractive, forming the basis for individual long and short positions. The funds also apply a disciplined approach to portfolio construction and risk management.
Doll says: “We are delighted to be partnering with Schroders through its prestigious GAIA platform to offer investors outside of the US access to these strategies. Our combination of intensive quantitative and qualitatitive investment research is designed to give investors the best possible chance of delivering robust absolute returns from US markets.”
